Evidence map›Paper›PMID 27588004›Full record

ArticleFrontiers in pharmacology2016

Involvement of Type 1 Angiontensin II Receptor (AT1) in Cardiovascular Changes Induced by Chronic Emotional Stress: Comparison between Homotypic and Heterotypic Stressors.

Willian Costa-Ferreira, Jonas O Vieira, Jeferson Almeida, Lucas Gomes-de-Souza, Carlos C Crestani

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Ang II-mediated effects on BBB integrity in psychiatric and neurological disorders.Progress in neuro-psychopharmacology & biological psychiatry · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Observational
  11. Article
  12. ATPflugers Archiv : European journal of physiology · 2019
    Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Willian Costa-FerreiraFaculdade de Ciências Farmacêuticas, UNESP-Universidade Estadual PaulistaAraraquara, Brazil; Joint UFSCar-UNESP Graduate Program in Physiological Sciences, UFSCar-UNESPSão Carlos, Brazil.
Jonas O VieiraFaculdade de Ciências Farmacêuticas, UNESP-Universidade Estadual PaulistaAraraquara, Brazil; Joint UFSCar-UNESP Graduate Program in Physiological Sciences, UFSCar-UNESPSão Carlos, Brazil.
Jeferson AlmeidaFaculdade de Ciências Farmacêuticas, UNESP-Universidade Estadual PaulistaAraraquara, Brazil; Joint UFSCar-UNESP Graduate Program in Physiological Sciences, UFSCar-UNESPSão Carlos, Brazil.
Lucas Gomes-de-SouzaFaculdade de Ciências Farmacêuticas, UNESP-Universidade Estadual PaulistaAraraquara, Brazil; Joint UFSCar-UNESP Graduate Program in Physiological Sciences, UFSCar-UNESPSão Carlos, Brazil.
Carlos C CrestaniFaculdade de Ciências Farmacêuticas, UNESP-Universidade Estadual PaulistaAraraquara, Brazil; Joint UFSCar-UNESP Graduate Program in Physiological Sciences, UFSCar-UNESPSão Carlos, Brazil.
Universidade Federal de São Carlos · BRUniversidade Estadual Paulista (Unesp) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Consistent evidence has shown an important role of emotional stress in pathogenesis of cardiovascular diseases. Additionally, studies in animal models have demonstrated that daily exposure to different stressor (heterotypic stressor) evokes more severe changes than those resulting from repeated exposure to the same aversive stimulus (homotypic stressor), possibly due to the habituation process upon repeated exposure to the same stressor. Despite these pieces of evidence, the mechanisms involved in the stress-evoked cardiovascular dysfunction are poorly understood. Therefore, the present study investigated the involvement of angiotensin II (Ang II) acting on the type 1 Ang II receptor (AT1) in the cardiovascular dysfunctions evoked by both homotypic and heterotypic chronic emotional stresses in rats. For this purpose, we compared the effect of the chronic treatment with the AT1 receptor antagonist losartan (30 mg/kg/day, p.o.) on the cardiovascular and autonomic changes evoked by the heterotypic stressor chronic variable stress (CVS) and the homotypic stressor repeated restraint stress (RRS). RRS increased the sympathetic tone to the heart and decreased the cardiac parasympathetic activity, whereas CVS decreased the cardiac parasympathetic activity. Additionally, both stressors impaired the baroreflex function. Alterations in the autonomic activity and the baroreflex impairment were inhibited by losartan treatment. Additionally, CVS reduced the body weight and increased the circulating corticosterone; however, these effects were not affected by losartan. In conclusion, these findings indicate the involvement of angiotensin II/AT1 receptors in the autonomic changes evoked by both homotypic and heterotypic chronic stressors. Moreover, the present results provide evidence that the increase in the circulating corticosterone and body weight reduction evoked by heterotypic stressors are independent of AT1 receptors.

Indexed as

autonomicbaroreflexcardiovascularchronic variable stresslosartanrestraint stress

Identifiers

PMID27588004
PMCPMC4988975
OpenAlexW2510373438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.